Back to results
US 5,965,129 AGranted
Two novel human cathespin proteins
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Roger Coleman
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Roger Coleman
Estimating the term…
The present invention provides two novel human cathepsin proteins (HCPs) and polynucleotides encoding HCPs. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding HCPs. The invention also provides for the production and use of antibodies to HCPs in pharmaceutical compositions for the treatment of disease processes that include cancers, inflammation, metastasis and peptide and proenzyme processing. In addition, the invention provides for the production and use of inhibitors of HSPs in pharmaceutical compositions for the treatment of diseases. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts encoding HCPs. The invention also provides for the use of antisense molecules in pharmaceutical compositions as therapeutics in cancers, inflammation, metastasis and peptide and proenzyme processing.
A substantially purified human cathepsin polypeptide comprising the amino acid sequence of SEQ ID NO:1, or immunologically active fragments thereof.
A pharmaceutical composition comprising a substantially purified human cathepsin protein having the amino acid sequence of SEQ ID NO:1 in conjunction with a suitable pharmaceutical carrier.
Dependencies are inferred from the claim text.